Bagratuni et al. [53] analyzed 200 MM patients in therapy with lenalidomide-based regimens, showing that, in patients that received low-dose aspirin as prophylaxis, rs3774968 in the NFKB1 gene was associated with an increased risk of VTE. Here, NFKB1 is linked to Miyoshi myopathy.